Vaccine News and Research

Latest Vaccine News and Research

Breakthrough in development of effective therapy against Hendra virus

A team of Federal and university scientists reports a breakthrough in the development of an effective therapy against a deadly virus, Hendra virus. The results of their study, "A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge," will appear in Science Translational Medicine online.

20 Oct 2011

Winter health and safety tips

Winter is a special time for celebration. It should also be a time for added caution if you or someone in your family is an older adult. It is the season for falls, slips on icy streets, and other dangers that can be especially harmful for older adults. "Something as simple as a fall can be devastating for older men and women," says Dr. Evelyn Granieri, director of the Division of Geriatrics at NewYork-Presbyterian Hospital/The Allen Hospital. "Before the cold weather arrives, it is important to prepare."

20 Oct 2011

Despite progress in malaria vaccine development, funding remains potential stumbling block

In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."

20 Oct 2011

Experimental vaccine halves risk of malaria in African children, results of large clinical trial suggest

"An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease," according to a study "presented at the Bill & Melinda Gates Foundation's Malaria Forum conference in Seattle and published simultaneously in the New England Journal of Medicine" on Tuesday, Reuters reports.

20 Oct 2011

Comprehensive roadmap promises to improve cancer immunotherapy development

The Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute (CRI) and the Association for Cancer Immunotherapy (CIMT) have issued a joint white paper, published in the October 13 issue of Nature Biotechnology, outlining a comprehensive roadmap that promises to help improve and facilitate the path forward in the development of novel immunotherapies for cancer.

19 Oct 2011

Link between development of new lymphoid tissue within the lung and protection against TB

New research from the Trudeau Institute may help in the ongoing fight against tuberculosis. Dr. Andrea Cooper's lab has discovered a connection between the development of new lymphoid tissue within the lung and protection against the disease.

19 Oct 2011

New form of respiratory distress syndrome in newborn mice

A discovery by scientists at the Salk Institute for Biological Studies might explain why some premature infants fail to respond to existing treatments for a deadly respiratory distress syndrome (RDS) and offers clues for new ways to treat the breathing disorder.

19 Oct 2011

Nearly one-third of all countries affected by malaria on course to eliminate disease, WHO report says

"Nearly a third of all countries affected by malaria are on course to eliminate the mosquito-borne disease over the next 10 years, the World Health Organization (WHO) said on Monday ... in a progress report published by the Roll Back Malaria (RBM) partnership at the start of an international Malaria Forum conference in Seattle," Reuters reports.

19 Oct 2011

RTS,S vaccine reduces risk of severe malaria in African children

First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.

19 Oct 2011

Malaria elimination could be a reality soon

Malaria – a mosquito borne illness kills more than 780,000 people a year worldwide. Nearly a third of all countries affected by malaria are on course to eliminate the mosquito-borne disease over the next 10 years, the World Health Organization (WHO) said on Monday.

18 Oct 2011

First results from phase 3 malaria vaccine candidate trial

18 Oct 2011

New promise of a malaria vaccine

New results published today in the New England Journal of Medicine about a large-scale Phase III trial conducted in seven African countries of the malaria vaccine candidate RTS,S deserve a hearty round of applause.

18 Oct 2011

Los Angeles Times examines polio eradication campaigns in Pakistan

The Los Angeles Times examines polio eradication campaigns in Pakistan, which is one of just four countries where the disease remains endemic.

18 Oct 2011

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Johnson & Johnson today announced sales of $16.0 billion for the third quarter of 2011, an increase of 6.8% as compared to the third quarter of 2010. Operational results increased 2.6% and the positive impact of currency was 4.2%. Domestic sales declined 3.7%.

18 Oct 2011

Beyond 9-9-9: Herman Cain on health policy

As GOP presidential hopeful Herman Cain's polling numbers surge, the Wall Street Journal examines his positions on health policy. Meanwhile, in other news from the Republican primary race, the Des Moines Register reports that Michele Bachmann is warning that the Supreme Court cannot be trusted to undo the health law, while the Texas Tribune takes a look at Rick Perry and Planned Parenthood.

18 Oct 2011

VEC and AMA release updated information guide, 'Vaccines and Teens'

This week at the annual meeting of the American Academy of Pediatrics, the Vaccine Education Center at The Children's Hospital of Philadelphia (VEC) and the American Medical Association released an updated information guide called Vaccines and Teens for parents and physicians, detailing the most current recommendations and information about critical immunizations for older children.

18 Oct 2011

Researchers discover peacekeeper-immune cells in outer layers of human skin

There are more bacteria living on our skin and in our gut than cells in our body. We need them. But until now no-one knew how the immune system could tell that these bacteria are harmless.

18 Oct 2011

Two genetic variants associated with increased susceptibility to severe dengue

Researchers in South East Asia have identified two genetic variants associated with increased susceptibility to severe dengue. The study, funded by the Wellcome Trust and the Agency for Science, Technology, and Research, Singapore, offers clues to how the body responds to dengue infection.

18 Oct 2011

Scientists discover a way to accurately map typhoid outbreaks in the city

In the mid-nineteenth century, John Snow mapped cases of cholera in Soho, London, and traced the source of the outbreak to a contaminated water pump. Now, in a twenty-first century equivalent, scientists funded by the Wellcome Trust working in Kathmandu, Nepal, have combined the latest in gene sequencing technology and global positioning system (GPS) case localisation to map the spread of typhoid and trace its source.

18 Oct 2011

AAP President to outline efforts to advance agenda for children

O. Marion Burton, MD, FAAP, president of the American Academy of Pediatrics (AAP) will address attendees at 10:30 a.m. ET on Saturday,Oct. 15, 2011, at the AAP National Conference and Exhibition in Boston.

15 Oct 2011